Polymorphisms in Genes Involved in Nitric Oxide (NO) Signaling and the Risk for Late Normal Tissue Injury from Radiation Therapy (RT)

R. B. Mikkelsen,A. Alam,R. Cardnell,E. Howlett,L. Reshko,L. Walker,Y. Ning,M. Anscher

DOI: https://doi.org/10.1016/j.ijrobp.2012.07.1822

2012-01-01

Abstract:Late normal tissue injuries arising months to years post-RT adversely affect quality of life and survival. Evidence suggests that these late effects regardless of the tissue result from chronic oxidative stress and inflammation, causing the natural wound repair processes to go awry. Animal model and human studies demonstrate the importance of aberrant responses of tissue endothelium and NO-signaling in the development of late tissue toxicity. Polymorphisms in genes encoding NO regulatory factors (NOS, TGF-β, TNF-α, HO-1, NRF2, DDAH, GCH1, and ARG) may have predictive value for normal tissue toxicity. For example, a polymorphism in the promoter for the radiation-induced HO-1 (heme oxygenase-1) gene determines expression levels of the protein. HO-1 oxidizes heme to bilirubin and CO, both antioxidants and inhibitors of inflammation and fibrosis. Bilirubin also decreases TGF-levels in bronchoalveolar lavage. Nrf2 is an oxidative responsive transcription factor for HO-1. Therefore, we conducted a study in cancer patients with RT-induced late effects to determine possible association between polymorphisms in these genes and late RT- induced injury. Blood samples were obtained from 101 consenting adults who had previously received RT with curative intent for cancers of the head and neck, chest, abdomen or pelvis and demonstrated RT-induced late effects at the time the blood sample was obtained. Late effects assessed by the patient's radiation oncologist were defined by RTOG criteria for the tissue in question. The gene profiles of these patients were compared to the published distributions of the normal population (NIH SNP Database). Initial studies focused on the length of the GT repeat in the HO-1 promoter since the long allele (n>32 repeats) is associated with a sluggish transcriptional response to stress and three functional haplotypes, -653(A/G), -651 (A/G), -617 (A/C), in the promoter of NRF2. Patient population characteristics are: Male:Female = 58:43; white:African American:Other = 55:44:2; age (median:61; range: 20-85); Irradiated sites: headandneck (n = 57), breast (n = 33), lung (n = 6), GI (n = 4), Pelvic (n = 1). We compared the allele frequencies for the NRF2 promoter from our patients with the non-irradiated pool and find no significant differences in allele frequencies (p>0.10). However, we find the long allele (repeat>32) of the HO-1 promoter is associated with 3.5 times the risk for RT-induced late injury (Odds ratio 3.46 and 95% Confidence Interval 1.58-7.69). Our results suggest that the long (n>32) GT repeat of the HO-1 promoter is significantly associated with increased risk for RT-induced late effects. Analysis of other gene polymorphisms will be provided at the meeting.